Cytokinetics Inc Financial Flexibility Index
Cytokinetics Inc financial flexibility index. Cytokinetics Inc (CYTK) has a Financial Flexibility Index of -0.07x as of June 2026. Free cash flow of $-155.51 Million (operating CF $-159.84 Million minus capex $4.33 Million) represents 0% of total liabilities ($2.10 Billion). Explore CYTK capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Cytokinetics Inc (2002–2025)
Financial flexibility index of Cytokinetics Inc from 2002 to 2025. Historical Financial Flexibility Index trend for Cytokinetics Inc across 24 annual periods. Check Cytokinetics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Cytokinetics Inc Financial Flexibility Index by Year (2002–2025)
Cytokinetics Inc financial flexibility index by year from 2002 to 2025. Year-by-year free cash flow to debt coverage for Cytokinetics Inc. For the full cash flow conversion analysis, see Cytokinetics Inc cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | $-485.20 Million | $-510.01 Million | $2.08 Billion | ▲ +8.7% |
| 2024 | -0.26x | $-391.98 Million | $-395.89 Million | $1.54 Billion | ▲ +25.2% |
| 2023 | -0.34x | $-412.92 Million | $-414.33 Million | $1.21 Billion | ▼ -32.9% |
| 2022 | -0.26x | $-288.18 Million | $-299.52 Million | $1.12 Billion | ▼ -63.8% |
| 2021 | -0.16x | $-93.65 Million | $-142.52 Million | $597.46 Million | ▼ -429.6% |
| 2020 | 0.05x | $20.00 Million | $8.94 Million | $420.42 Million | ▲ +116.2% |
| 2019 | -0.29x | $-88.29 Million | $-90.91 Million | $300.75 Million | ▲ +45.8% |
| 2018 | -0.54x | $-100.33 Million | $-101.22 Million | $185.24 Million | ▼ -1.3% |
| 2017 | -0.53x | $-98.88 Million | $-101.76 Million | $184.97 Million | ▼ -205.0% |
| 2016 | 0.51x | $38.58 Million | $36.98 Million | $75.78 Million | ▲ +336.1% |
| 2015 | 0.12x | $5.45 Million | $4.88 Million | $46.65 Million | ▲ +110.9% |
| 2014 | -1.07x | $-43.74 Million | $-44.84 Million | $40.90 Million | ▼ -328.3% |
| 2013 | -0.25x | $-7.18 Million | $-7.72 Million | $28.75 Million | ▲ +95.4% |
| 2012 | -5.45x | $-33.31 Million | $-33.44 Million | $6.11 Million | ▲ +44.5% |
| 2011 | -9.83x | $-45.15 Million | $-45.59 Million | $4.59 Million | ▼ -65.7% |
| 2010 | -5.93x | $-44.34 Million | $-44.83 Million | $7.48 Million | ▼ -1500.3% |
| 2009 | 0.42x | $8.97 Million | $8.42 Million | $21.17 Million | ▲ +126.3% |
| 2008 | -1.61x | $-60.67 Million | $-61.33 Million | $37.69 Million | ▼ -20096.8% |
| 2007 | -0.01x | $-442.00K | $-3.00 Million | $55.45 Million | ▲ +98.8% |
| 2006 | -0.66x | $-41.80 Million | $-47.17 Million | $63.20 Million | ▲ +68.9% |
| 2005 | -2.12x | $-38.02 Million | $-39.48 Million | $17.90 Million | ▼ -33.7% |
| 2004 | -1.59x | $-32.63 Million | $-34.03 Million | $20.55 Million | ▼ -795.9% |
| 2003 | -0.18x | $-27.46 Million | $-30.51 Million | $154.90 Million | ▼ -31.6% |
| 2002 | -0.13x | $-15.73 Million | $-22.30 Million | $116.76 Million | — |